VSQM
HALO icon

V-Square Quantitative Management’s Halozyme HALO Stock Holding History

V-Square Quantitative Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-362
Closed -$23.4K – 747
2026
Q1 		$23.4K Hold
362
– – ﹤0.01% 687
2025
Q4 		$24.4K Buy
+362
New +$24.4K ﹤0.01% 674

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

V-Square Quantitative Management's HALO Position: Q2 2026 in Review

V-Square Quantitative Management sold out of Halozyme (HALO) in Q2 2026, closing a stake of 362 shares — an estimated $23.4K sold.

V-Square Quantitative Management first reported a position in HALO in Q4 2025 and held it in 2 quarters. The position peaked at $24.4K in Q4 2025. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • V-Square Quantitative Management reported no remaining Halozyme position as of Q2 2026 after selling out during the quarter.
  • V-Square Quantitative Management sold 362 Halozyme shares in Q2 2026, an estimated $23.4K.
  • V-Square Quantitative Management first reported a position in Halozyme in Q4 2025 and held it in 2 quarters.
  • V-Square Quantitative Management's Halozyme position peaked at $24.4K in Q4 2025.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on V-Square Quantitative Management's 13F filing for Q2 2026, filed 27 Jul 2026.